During the past decade, Nottingham Children's Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nottingham Children's Hospital" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Kyowa Kirin Pharmaceutical Development Ltd" with 1 trials sponsored, "OxThera" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nottingham Children's Hospital" #1 collaborator was "Alberta Children's Hospital" with 1 trials as a collaborator, "Andaluz Health Service" with 1 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Centre for Statistics in Medicine, Oxford" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Nottingham Children's Hospital" are "Abdomen, Acute" (1 trials), "Active Juvenile Psoriatic Arthritis" (1 trials), "Candidemia" (1 trials), "Carcinoma, Hepatocellular" (1 trials) and "Children, Only" (1 trials). Many other conditions were trialed in "Nottingham Children's Hospital" in a lesser frequency.

Most popular intervention types in "Nottingham Children's Hospital" are "Drug" (7 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "5Fluorouracil" (1 trials), "Aldesleukin" (1 trials), "Anidulafungin" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nottingham Children's Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Nottingham Children's Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nottingham Children's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nottingham Children's Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".